CCR5Δ32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C

Table 1 Demographic profile of patients with chronic HCV infection and healthy controls

	Patients(n = 252)	Patients(Only genotype 3)(n = 187)	Healthycontrols(n = 408)
Age (yr)
Mean ± SD	40 ± 14	40 ± 14	33 ± 7
Male: Female	164:88	118:69	297:111
ALT (IU/L)
Mean	112.3 ± 68.4	116 ± 70.1	29 ± 2
Range	(32-330)	(32-330)
S. Albumin (g/L)	36 ± 4	34 ± 5	40 ± 3
HCV genotype (n = 209)
I	17 (8.1%)		-
II	1 (0.5%)
III	187 (89.4%)		-
IV	4 (1.5%)		-
Liver Biopsy
Fibrosis score	2 ± 1	2 ± 1.2	-
HAI	5.5 ± 2.4	5.6 ± 2.5	-
Mode of Acquisition of HCV
Blood transfusion	86		-
Needle stick injury	54		-
Intravenous drug use	10		-
Medical procedure	45		-
Unclear	57